Amendment
CTN new england consortium node - in this administrative supplement, the new england consortium node (necn), led by gail d'onofrio MD, of yale university, and…
Alameda Health SystemThis project will develop and refine a prehospital EMS clinical field protocol to initiate buprenorphine in persons with OUD presenting with an overdose…
$1,477,718
University Of California, LOS AngelesThe Site PI will provide overall administrative oversight and programmatic deliverables and ensure meeting deadlines. With other Principal Investigators they…
$163,082
Howard UniversityHoward University is participating as a collaborating academic institution in the New England Consortium Node of the National Drug Abuse Treatment Clinical…
President And Fellows Of Harvard CollegeDr. Griffin Weber is an Associate Professor of Biomedical Informatics at Harvard Medical School, an Associate professor of Medicine at Beth Israel Deaconess…
$47,706
Hennepin Healthcare Research InstituteThe Site PI will provide overall administrative oversight and programmatic deliverables and ensure meeting deadlines. With other Principal Investigators they…
The Mclean Hospital CorporationMcLean Hospital is participating in the study as one of 18 sites across the country for this multi-site clinical trial. The McLean study site will continue…
$1,251,158
The Children's Hospital Of PhiladelphiaThis site will serve as a recruiting site for CTN-0146. The participating site will consist of a site principal investigator (PI), site study staff member…
$755,458
Beth Israel Deaconess Medical Center, Inc.Dr. Gabriel Brat is one of the Co-PIs on this project and will oversee all aspects of this proposed subaward. Dr. Brat will collaborate closely with Dr. Weber…
$446,154
Alameda Health SystemCTN0131 Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment- A Randomized Pragmatic Hybrid…
$1,380,591
Childrens Hospital Medical CenterCincinnati Children’s Hospital Medical Center (CCHMC) will serve as a recruiting site for CTN-0146. CCHMC will consist of two site principal investigators (PI),…
$634,880
The Rand CorporationDenis Agniel (site PI) and Gabriel Hassler are the statisticians on this project. They will interface between participating sites, research team, and PIs to…
$98,269
MainehealthThis site will serve as recruiting site for CTN-0145. Site Principal Investigator (PI) will provide overall administrative oversight and will be responsible for…
$835,949
Hennepin Healthcare Research InstituteWork to be performed at Northstar Node (Hennepin Healthcare Research Institute) via a subaward. Dr. Gavin Bart will be the subaward PI for this study site. Work…
$772,045
All Childrens Research Institute Inc.This site will serve as a recruiting site for CTN-0146. The participating site will consist of a site principal investigator (PI), site study staff member…
$256,711
Trustees Of Boston UniversityThis study has two main objectives: 1) to conduct a multisite open-label randomized comparative effectiveness trial of a 28-day formulation extended-release…
$335,632
Kaiser Foundation HospitalsThis subaward includes costs required for the conduct of CTN0131 supported by NIDA Clinical Trials Network through the New England Consortium Node, UG1DA015831.…
$1,033,381
Marshall University Research CorporationObjectives: 1. Determine whether office-based methadone with pharmacy administration and/or dispensing or buprenorphine (BUP) results in greater treatment…
$473,254
The Regents Of The University Of ColoradoThis site will serve as a recruiting site for CTN-0146. The participating site will consist of a site principal investigator (PI), site study staff member…
$507,687
The Children's Hospital CorporationBoston Children's Hospital (BCH) will serve as both the coordinating center and a recruitment site for CTN- 0146. Dr. Sharon Levy and Dr. Joseph Cravero will…
$4,125,208
Alameda Health SystemThis site will serve as recruiting site for CTN-0145. Site Principal Investigator (PI) will provide overall administrative oversight and will be responsible for…
Boston Medical Center CorporationThe study site principal investigator (PI), Zoe Weinstein, MD, will be responsible for oversight of all local scientific and administrative processes and…
The General Hospital CorporationDr. Wakeman will devote 0.36 calendar months (3%) each year of the project and will participate, with the New England Consortium Node (NECN), in the development…
$33,748
The Mclean Hospital CorporationThe infrastructure of the Clinical Trials Network(CTN) New England consortium Node operates through a Multiple PI grant mechanism. Roger D. Weiss, MD of…
$712,318
Boston Medical Center CorporationDr. Samet will devote 0.36 calendar months (3% effort) and Dr. Komaromy will devote 0.36 calendar months (3% effort) each year of the project and will…
$139,540
Show all 29
Quick answers
Who received award UG1DA015831?
UG1DA015831 was awarded to Yale Univ by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2002.
How much is award UG1DA015831 worth?
$722,268,421 has been obligated on UG1DA015831: $691,104,722 in federal funding and $31,163,699 in non-federal funding.